Market Currents
TPG agrees to acquire Par Pharmaceutical (PRX) for $1.9B, or $50/share, which represents a 37%...
-
Monday, July 16, 2012, 8:24 AM ETTPG agrees to acquire Par Pharmaceutical (PRX) for $1.9B, or $50/share, which represents a 37% premium over Par's closing price on Friday. Shares +36% premarket. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
